Medical Use
Adakveo is a selectin blocker used to reduce the frequency of painful crises in adults and pediatric patients aged 16 years and older with sickle cell disease (SCD).
Recommended Dosage: The recommended dosage of Adakveo is 5 mg per kg, administered via intravenous (IV) infusion over 30 minutes at Week 0, Week 2, and then every 4 weeks thereafter.
Missed Dose Instructions: If a dose is missed, administer it as soon as possible. If given within 14 days of the missed dose, continue with the regular dosing schedule. If administered more than 14 days after the missed dose, resume dosing every 28 days (4 weeks) thereafter. Adakveo can be used with or without hydroxyurea.
Warning & Precautions
Infusion-related reactions can occur in patients receiving Adakveo 100 mg/10 mL (10 mg/mL). Patients should be closely monitored for such reactions. If serious reactions occur, discontinue Adakveo infusion and provide appropriate medical care.
Platelet Count Interference: Adakveo 100 mg injection may cause platelet clumping, particularly when blood samples are collected in EDTA (ethylenediaminetetraacetic acid) tubes. Mitigation strategies may be necessary.
Pregnancy Risks: Crizanlizumab can cause fetal loss if administered to pregnant women. Therefore, it is advised to avoid using Adakveo during pregnancy and in women of childbearing age who are not using contraception.
Effects on Driving and Machinery: Adakveo 100 mg/10 mL (10 mg/mL) solution may slightly affect the ability to drive and operate machinery. Fatigue, dizziness, and drowsiness may occur after administration.
Documentation Availability
ADAKVEO® (crizanlizumab-tmca) injection can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing ADAKVEO® (Cancer Treatment Medicines) around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is the Generic Name for Adakveo®?
The generic name for Adakveo® is crizanlizumab-tmca.
Who manufactures Adakveo®?
Adakveo® is manufactured by Novartis Pharmaceuticals Corporation.
Is Adakveo® FDA approved?
Yes, Adakveo® was approved by the FDA on November 15, 2019.
What is the dosage form of Adakveo®?
Adakveo® is available as an injection: 100 mg/10 mL solution in a single-dose vial for intravenous (IV) administration.
What are the common side effects of Adakveo®?
Common side effects include nausea, back pain, joint pain, and fever.
How much does Adakveo® cost in India?
The cost of Adakveo® in India can vary. To purchase it legally, you can reach out to Rx4u team.
How should Adakveo® be stored?
Store and transport Adakveo® refrigerated at 2-8°C (36-46°F) in its original carton to protect from light. Do not shake or freeze.
How to order Adakveo® online in India?
Adakveo® can be ordered online in India through https://rx4u.in/.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
